{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05580172",
            "orgStudyIdInfo": {
                "id": "RHV18002"
            },
            "organization": {
                "fullName": "ReHeva Biosciences,Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer",
            "officialTitle": "A Phase 1 Open Label Dose Ranging Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer",
            "therapeuticArea": [
                "Other"
            ],
            "study": "phase-study-of-oral-in-advanced-non-small-cell-lung-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-06-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-10-11",
            "studyFirstSubmitQcDate": "2022-10-11",
            "studyFirstPostDateStruct": {
                "date": "2022-10-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-10-13",
            "lastUpdatePostDateStruct": {
                "date": "2022-10-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ReHeva Biosciences,Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Phase 1 open label dose ranging study of RH324 in advanced non-small cell lung cancer",
            "detailedDescription": "This is a Phase 1 open label dose ranging study to assess the safety and tolerability of oral RH324 in advanced non-small cell lung cancer"
        },
        "conditionsModule": {
            "conditions": [
                "Safety Issues"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 6,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "RH324",
                    "interventionNames": [
                        "Drug: RH324"
                    ]
                },
                {
                    "label": "Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "RH324",
                    "interventionNames": [
                        "Drug: RH324"
                    ]
                },
                {
                    "label": "Dose Level 3",
                    "type": "EXPERIMENTAL",
                    "description": "RH324",
                    "interventionNames": [
                        "Drug: RH324"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "RH324",
                    "description": "polymolecular",
                    "armGroupLabels": [
                        "Dose Level 1",
                        "Dose Level 2",
                        "Dose Level 3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Adverse Events Per Common Terminology Criteria for Adverse Events Version 5",
                    "description": "Percentage of Adverse Events Summarized by Causality and Grade",
                    "timeFrame": "Through Study Completion 28 Days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of Subjects with a Change from Baseline on Physical Examination and Vital Signs",
                    "description": "Percentage of Subjects with a Clinically Relevant Change from Baseline on Physical Exam and Vital Signs",
                    "timeFrame": "Through Study Completion 28 Days"
                },
                {
                    "measure": "Percentage of Subjects with a Change from Baseline on Laboratory Values",
                    "description": "Percentage of Subjects with a Clinically Relevant Change from Baseline on Blood and Urine Laboratory Values",
                    "timeFrame": "Through Study Completion 28 Days"
                },
                {
                    "measure": "Percentage of Subjects with a Change from Baseline on the Electrocardiogram",
                    "description": "Percentage of Subjects with a Clinically Relevant Change from Baseline on the 12-Lead Electrocardiogram",
                    "timeFrame": "Through Study Completion 28 Days"
                },
                {
                    "measure": "Percentage of Subjects with a Change from Baseline in Quality of Life",
                    "description": "Percentage of Subjects with a Clinically Relevant Change from Baseline in Quality of Life Based on the Eastern Cooperative Oncology Group Performance Status Levels",
                    "timeFrame": "Through Study Completion 28 Days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Advanced Non-Small Cell Lung Cancer\n* Measurable Target Lesion by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1\n* Failed all standard of care including chemotherapy, targeted therapy, and immunotherapy\n* Adults over 18 years\n* Performance status (Eastern Cooperative Oncology Group) less than or equal to 2\n* Life expectancy greater than 2 months\n* Laboratory Values:\n\nHemoglobin greater than or equal to 9; neutrophils greater than 1,000; platelets greater than 50,000 Liver function tests less than or equal to twice upper limit of normal Serum Creatinine less than or equal to 2 Creatinine clearance greater than or equal to 30 mL per minute Hemoglobin A1C less than 7 Normal Thyroid function\n\n* No history of hyperthyroidism\n* Abstinence from alcohol and supplements\n* Not pregnant, lactating and willing to use birth control throughout study\n* Able to provide consent\n* Positive Emission Tomography/Computer Tomography part of subjects care plan at baseline\n\nExclusion Criteria:\n\n* Prior use of Withania somnifera\n* Phenylketonuria\n* Inability to swallow capsules\n* Hypersensitivity to study drug ingredients\n* Unstable medical or surgical condition\n* History of additional cardiac risk factors\n* Requiring drugs that are \"strong\" inhibitors of cytochrome P450\n* Requiring irradiation\n* Requiring intravenous fluids or hyperalimentation\n* Requiring transfusions, dialysis, or other procedures\n* Active infection\n* Human Immunodeficiency Virus\n* Must exceed washout period of prior treatments\n* Psychiatric, neurological or other reason that precludes subjects ability to participate",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Charles Packard",
                    "role": "CONTACT",
                    "phone": "517-518-8194",
                    "email": "Charles.packard@parexel.com"
                }
            ],
            "locations": [
                {
                    "facility": "Case Comprehensive Cancer Center University Hospitals",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Afshin Dowlati, MD",
                            "role": "CONTACT",
                            "phone": "216-844-5181",
                            "email": "Afshin.Dowlati@UHhospitals.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}